225 related articles for article (PubMed ID: 11342461)
1. Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice.
Kushida T; Inaba M; Hisha H; Ichioka N; Esumi T; Ogawa R; Iida H; Ikehara S
Blood; 2001 May; 97(10):3292-9. PubMed ID: 11342461
[TBL] [Abstract][Full Text] [Related]
2. Treatment of intractable autoimmune diseases in MRL/lpr mice using a new strategy for allogeneic bone marrow transplantation.
Kushida T; Inaba M; Takeuchi K; Sugiura K; Ogawa R; Ikehara S
Blood; 2000 Mar; 95(5):1862-8. PubMed ID: 10688849
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow transplantation: a new strategy for intractable diseases.
Ikehara S
Drugs Today (Barc); 2002 Feb; 38(2):103-11. PubMed ID: 12532188
[TBL] [Abstract][Full Text] [Related]
4. Crucial role of donor-derived stromal cells in successful treatment for intractable autoimmune diseases in mrl/lpr mice by bmt via portal vein.
Kushida T; Inaba M; Hisha H; Ichioka N; Esumi T; Ogawa R; Iida H; Ikehara S
Stem Cells; 2001; 19(3):226-35. PubMed ID: 11359948
[TBL] [Abstract][Full Text] [Related]
5. A new strategy for treatment of autoimmune diseases in chimeric resistant MRL/lpr mice.
Takeuchi K; Inaba M; Miyashima S; Ogawa R; Ikehara S
Blood; 1998 Jun; 91(12):4616-23. PubMed ID: 9616158
[TBL] [Abstract][Full Text] [Related]
6. Treatment of autoimmune diseases in MRL/lpr mice by allogenic bone marrow transplantation plus adult thymus transplantation.
Hosaka N; Ryu T; Miyake T; Cui W; Nishida T; Takaki T; Inaba M; Ikehara S
Clin Exp Immunol; 2007 Mar; 147(3):555-63. PubMed ID: 17302907
[TBL] [Abstract][Full Text] [Related]
7. New strategies for BMT, organ transplantation, and regeneration therapy.
Ikehara S
Hematology; 2003 Apr; 8(2):77-81. PubMed ID: 12745656
[TBL] [Abstract][Full Text] [Related]
8. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor.
Ishida T; Inaba M; Hisha H; Sugiura K; Adachi Y; Nagata N; Ogawa R; Good RA; Ikehara S
J Immunol; 1994 Mar; 152(6):3119-27. PubMed ID: 8144907
[TBL] [Abstract][Full Text] [Related]
9. Presence of donor-derived thymic epithelial cells in [B6-->MRL/lpr] mice after allogeneic intra-bone marrow-bone marrow transplantation (IBM-BMT).
Takaki T; Hosaka N; Miyake T; Cui W; Nishida T; Inaba M; Ikehara S
J Autoimmun; 2008 Dec; 31(4):408-15. PubMed ID: 19022623
[TBL] [Abstract][Full Text] [Related]
10. Prevention of lpr-graft-versus-host disease and transfer of autoimmune diseases in normal C57BL/6 mice by transplantation of bone marrow cells plus bones (stromal cells) from MRL/lpr mice.
Miyashima S; Nagata N; Nakagawa T; Hosaka N; Takeuchi K; Ogawa R; Ikehara S
J Immunol; 1996 Jan; 156(1):79-84. PubMed ID: 8598497
[TBL] [Abstract][Full Text] [Related]
11. Treatment of autoimmune diseases in mice by a new method for allogeneic bone marrow transplantation.
Ikehara S
Ther Apher Dial; 2003 Jun; 7(3):292-7. PubMed ID: 12924603
[TBL] [Abstract][Full Text] [Related]
12. Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation.
Ikehara S; Yasumizu R; Inaba M; Izui S; Hayakawa K; Sekita K; Toki J; Sugiura K; Iwai H; Nakamura T
Proc Natl Acad Sci U S A; 1989 May; 86(9):3306-10. PubMed ID: 2654943
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow transplantation for autoimmune diseases.
Ikehara S
Acta Haematol; 1998; 99(3):116-32. PubMed ID: 9587393
[TBL] [Abstract][Full Text] [Related]
14. Prevention of autoimmune hearing loss in MRL/lpr mice by bone marrow transplantation.
Lee S; Iwai H; Sugiura K; Takeuchi K; Kushida T; Tomoda K; Inaba M; Yamashita T; Ikehara S
Bone Marrow Transplant; 2000 Oct; 26(8):887-92. PubMed ID: 11081390
[TBL] [Abstract][Full Text] [Related]
15. Analyses of acute graft-versus-host-like reaction in [MRL/lpr----MRL/+] chimeric mice using MRL/lpr-Thy-1. 1 congenic mice.
Nakagawa T; Nagata N; Hosaka N; Inaba M; Yasumizu R; Ogawa R; Ikehara S
Cell Immunol; 1991 Oct; 137(1):189-99. PubMed ID: 1679378
[TBL] [Abstract][Full Text] [Related]
16. New strategies for allogeneic BMT.
Ikehara S
Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S73-5. PubMed ID: 12931248
[TBL] [Abstract][Full Text] [Related]
17. The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation.
Jiang Z; Adams GB; Hanash AM; Scadden DT; Levy RB
Biol Blood Marrow Transplant; 2002; 8(11):588-96. PubMed ID: 12463477
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow transplantation as a strategy for the treatment of autoimmune hearing loss in MRL/Mp-lpr/lpr mice.
Iwai H; Lee S; Inaba M; Baba S; Yamashita T; Ikehara S
J Neuroimmunol; 2005 Nov; 168(1-2):76-82. PubMed ID: 16146652
[TBL] [Abstract][Full Text] [Related]
19. Facilitation of hematopoietic recovery by bone grafts with intra-bone marrow-bone marrow transplantation.
Song C; Hisha H; Wang X; Li Q; Li M; Cui W; Guo K; Okazaki S; Mizokami T; Kato J; Cui Y; Feng W; Zhang Y; Shi M; Inaba M; Fan H; Ikehara S
Immunobiology; 2008; 213(6):455-68. PubMed ID: 18514748
[TBL] [Abstract][Full Text] [Related]
20. Prevention of graft-versus-host disease by intra-bone marrow injection of donor T cells.
Fukui J; Inaba M; Ueda Y; Miyake T; Hosaka N; Kwon AH; Sakaguchi Y; Tsuda M; Omae M; Kamiyama Y; Ikehara S
Stem Cells; 2007 Jun; 25(6):1595-601. PubMed ID: 17446564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]